Toggle light / dark theme

57:03 “A tool that would be used for millenia.”


Foresight biotech & health extension group sponsored by 100 plus capital.

Accelerator applications are open now: https://foresight.org/biotech-health-extension-program.

Industry blindspots: Unincentivized work that could dramatically advance progress on aging.

SONIA ARRISON, 100 Plus Capital.
Sonia Arrison is a best-selling author, analyst, entrepreneur, and investor. She is the founder of 100 Plus Capital, co-founder of Unsugarcoat Media (acquired by Medium), and associate founder and advisor to Singularity University in Mountain View, California. Her research focuses on exponentially growing technologies and their impact on society. Her most recent book, 100 Plus: How the Coming Guests Age of Longevity Will Change Everything, From Careers and Relationships to Family and Faith, addresses the social, economic, and cultural impacts of radical human longevity. It gained national bestseller status and keeps Sonia busy speaking all over the world. Sonia is a Board Member at the Thiel Foundation, Foresight Institute, and Woodland School. She is also a Senior Fellow at the Fraser Institute in Vancouver, British Columbia, and author of two previous books (Western Visions and Digital Dialog). She was previously a Director and Senior Fellow in Tech Studies at the Pacific Research Institute and a columnist at TechNewsWorld.

KARL PFLEGER, Agingbiotech.info.
Karl Pfleger, PhD (Stanford CS, Machine Learning) now focuses on aging & longevity after a successful tech career (mySimon, Google). A long-time donor to the Buck Institute and SENS Foundation, he is also an angel investor who has backed over 15 agingrelated startups. He is the creator of AgingBiotech. info, a free public resource to track the commercialization progress of the aging biotech sector and related information.

MIKE WEST, AgeX
Michael D. West, Ph.D., is the founder and CEO of AgeX Therapeutics, Inc, which is focused on the development and commercialization of novel therapeutics targeting human aging. He received his Ph.D. from Baylor College of Medicine in 1989 concentrating on the biology of cellular ageing. He has focused his academic and business career on the application of developmental biology to agerelated degenerative disease. He was the founder and first CEO of Geron Corporation (Nasdaq: GERN), and from 1992 to 1998, he held various positions, including CEO, Director, and Vice President. From 1998 to 2007, Dr West held positions as CEO, President, and Chief Scientific Officer at Advanced Cell Technology, Inc. (ACT), which was eventually acquired by Astellas Pharma, Inc. From 2007 to 2018, he was CEO/Co-CEO of BioTime, Inc. (NYSE American: BTX).

Zoom Transcription:
https://otter.ai/u/kGO_zgxGxUbbd63_6wfM0x_RQsA

Now Sweeney, 50, is embarking on the biggest battle in his company’s 30-year history: Epic is suing Apple and Google in a legal challenge that could remake the future of the digital economy.


Over the course of his career Tim Sweeney has been unafraid to take on tech industry giants.

That’s not to say Taiwan is the only player in the semiconductor supply chain. The U.S. still holds dominant positions, notably in chip design and electronic software tools; ASML Holding NV of the Netherlands has a monopoly on the machines needed to fabricate the best chips; Japan is a key supplier of equipment, chemicals and wafers.


U.S., European and Japanese automakers are lobbying their governments for help, with Taiwan and TSMC being asked to step in. Chancellor Angela Merkel and President Emmanuel Macron discussed the potential for shortages last year and agreed on the need to accelerate Europe’s push to develop its own chip industry, according to a French official with knowledge of the matter.

The auto industry’s pleas illustrate how TSMC’s chip-making skills have handed Taiwan political and economic leverage in a world where technology is being enlisted in the great power rivalry between the U.S. and China — a standoff unlikely to ease under the administration of Joe Biden.

Taiwan’s grip on the semiconductor business — despite being under constant threat of invasion by Beijing — also represents a choke point in the global supply chain that’s giving new urgency to plans from Tokyo to Washington and Beijing to increase self-reliance.

Hyosung Chairman Hyun-Joon Cho has begun to activate the hydrogen economy by preparing to construct the world’s largest liquid hydrogen factory following a large-scale investment in carbon fiber last year.

Hyosung joined hands with the Linde Group, a global chemical company specializing in industrial gas, to establish a value chain encompassing the production and transportation of liquid hydrogen and installation and operation of charging stations by investing KRW 300 billion in all by 2022. For this purpose, an MOU was signed by Hyosung Chairman Hyun-Joon Cho and Linde Korea Chairman Baek-Seok Seong on April 28 at the head office of Hyosung in Mapo, Seoul.

To expand charging infrastructure by constructing a liquid hydrogen factory with annual production capacity of 13000 tons in Yongyeon by 2022.

In the coming Age of Superintelligence [and automation] everyone should be entitled to social dividend, “free” money such as UBI, just for being alive. We should not forget that the wealthiest of us would not be as fortunate without civilization. Otherwise, Jeff Bezos would have to forage for food in the Amazon jungle all by himself. Being a human today is more than enough of a fair contribution to receive free money from the government. Going forward we’ll see more and more prominent voices vouching for UBI.

#HybridEconomy #UniversalBasicIncome #UBI #BasicIncome #SocialDividend #TaxWallStreet #WealthTax #InheritanceTax

Though vaccination has begun to fall in some cases, epidemiologists say rapid tests may be the only way to reopen economy.

Join our COVID platform!


The University of California, Davis, is providing free testing, masks and quarantine housing to tens of thousands of people who live nearby.

President Joe Biden plans to replace the government’s fleet of cars and trucks with electric vehicles assembled in the U.S., he said Monday when signing a new “Buy America” executive order.

The government is a major purchaser of vehicles. However, replacing such a fleet with American-produced EVs will be costly and take time. There are currently only a handful of all-electric vehicles being assembled in the U.S. Tesla, General Motors and Nissan Motor produce EVs domestically, while Ford Motor and others have announced plans to do so.

“The current offerings are pretty slim, but the industry’s about to unleash an avalanche of new product, and a lot of it built in North America,” Kristin Dziczek, vice president of industry, labor and economics at the Center for Automotive Research, told CNBC. “Just about every U.S. plant is going to have a hybrid or electric product.”

What do you think Eric Klien.


A universal basic income worth about one-fifth of workers’ median wages did not reduce the amount of effort employees put into their work, according to an experiment conducted by Spanish economists, a sign that the policy initiative could help mitigate inequalities and the impact of automation.

Providing workers with a universal basic income did not reduce the amount of effort they put into their work, according to an experiment conducted by Spanish economists, a sign that the policy initiative could help mitigate inequalities and debunking a common criticism of the proposal.

Examining a universal basic income worth about one-fifth of workers’ median wages, the researchers also found that the threat of being replaced by robots did not impact workers’ productivity, nor did a tax on firms when they replace a worker with a robot or automated process, though the latter successfully created a disincentive for managers.